Cargando…
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807464/ https://www.ncbi.nlm.nih.gov/pubmed/36394581 http://dx.doi.org/10.1007/s00277-022-05035-y |
| _version_ | 1784862725130682368 |
|---|---|
| author | Strüßmann, Tim Jung, Johannes Heinz, Jürgen Duque Afonso, Jesus Wäsch, Ralph Engelhardt, Monika Duyster, Justus Finke, Jürgen Marks, Reinhard |
| author_facet | Strüßmann, Tim Jung, Johannes Heinz, Jürgen Duque Afonso, Jesus Wäsch, Ralph Engelhardt, Monika Duyster, Justus Finke, Jürgen Marks, Reinhard |
| author_sort | Strüßmann, Tim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9807464 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98074642023-01-04 Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab Strüßmann, Tim Jung, Johannes Heinz, Jürgen Duque Afonso, Jesus Wäsch, Ralph Engelhardt, Monika Duyster, Justus Finke, Jürgen Marks, Reinhard Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-11-17 2023 /pmc/articles/PMC9807464/ /pubmed/36394581 http://dx.doi.org/10.1007/s00277-022-05035-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Strüßmann, Tim Jung, Johannes Heinz, Jürgen Duque Afonso, Jesus Wäsch, Ralph Engelhardt, Monika Duyster, Justus Finke, Jürgen Marks, Reinhard Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab |
| title | Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab |
| title_full | Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab |
| title_fullStr | Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab |
| title_full_unstemmed | Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab |
| title_short | Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab |
| title_sort | long-term complete remission of refractory severe idiopathic immune thrombocytopenia (itp) treated with daratumumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807464/ https://www.ncbi.nlm.nih.gov/pubmed/36394581 http://dx.doi.org/10.1007/s00277-022-05035-y |
| work_keys_str_mv | AT strußmanntim longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT jungjohannes longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT heinzjurgen longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT duqueafonsojesus longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT waschralph longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT engelhardtmonika longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT duysterjustus longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT finkejurgen longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab AT marksreinhard longtermcompleteremissionofrefractorysevereidiopathicimmunethrombocytopeniaitptreatedwithdaratumumab |